Key result
Preoperative portal vein thrombosis was a significant risk factor for intraoperative intracardiac thrombosis or pulmonary embolism, which occurred in 25% of multivisceral transplants (P=0.0073).
Why the study?
What is the incidence and what are the risk factors for thrombotic and hemorrhagic complications during and after visceral transplantation?
Cohort (n=48)
No
What is the incidence and what are the risk factors for thrombotic and hemorrhagic complications during and after visceral transplantation?
Multivisceral transplant recipients with preoperative portal vein thrombosis are at high risk for life-threatening intraoperative intracardiac thrombosis and pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Supports heightened intraoperative monitoring in multivisceral transplant recipients with portal vein thrombosis; leaves open optimal thromboprophylaxis strategies.
This study describes the risk of thrombotic and hemorrhagic complications, both intraoperatively, and up to 1 month following visceral transplantation. Data from 48 adult visceral transplants performed between 2010 and 2017 were retrospectively studied [32 multivisceral (MVTx); 10 isolated intestine; six modified-MVTx]. Intraoperatively, intracardiac thrombosis (ICT)/pulmonary embolism (PE) occurred in 25%, 0% and 0% of MVTx, isolated intestine and modified MVTx, respectively, and was associated with 50% (4/8) mortality. Preoperative portal vein thrombosis (PVT) was a significant risk factor for ICT/PE (P = 0.0073). Thromboelastography resembling disseminated intravascular coagulation (DIC) (r time <4 mm combined with fibrinolysis or flat-line) was statistically associated with occurrence of ICT/PE (P < 0.0001). Compared to subgroup without ICT/PE, occurrence of ICT/PE was associated with an increased demand for all blood product components both overall, and each surgical stage. Hyperfibrinolysis (56%) was identified as cause of bleeding in MVTx. Incidence of postoperative thrombotic event at 1 month was 25%, 30% and 17% for MVTx, isolated intestine and modified MVTx, respectively. Incidence of postoperative bleeding complications at 1 month was 11%, 20% and 17% for MVTx, isolated intestine and modified MVTx. In conclusion, MVTx recipients with preoperative PVT are at an increased risk of developing intraoperative life-threatening ICT/PE events associated with DIC-like coagulopathy.
No takes yet. Share an insight, caveat, or question.
Raveh et al. (2018) conducted a cohort in Visceral transplantation (n=48). Preoperative portal vein thrombosis (PVT) vs. No preoperative PVT was evaluated on Intraoperative intracardiac thrombosis (ICT) or pulmonary embolism (PE) (p=0.0073). Preoperative portal vein thrombosis was a significant risk factor for intraoperative intracardiac thrombosis or pulmonary embolism, which occurred in 25% of multivisceral transplants (P=0.0073).
Synapse has enriched 10 related papers. Consider them for comparative context: